The last story in today's Vidyya is perhaps the most important from a public health standpoint. Wyeth-Ayerst is halting all shipments of the Norplant contraceptive system until problems with shelf-life stability are addressed. Certain lots of the contraceptive failed stability tests. The pharmaceutical company and the FDA are working to rectify the situation.
In other news, children who assign negative emotions to their parents drinking may develop a strong aversion to alcohol. The new research may hold the key to helping prevent underage drinking. Since underage drinking is a family issue, we've included a brochure for parents on how to talk to their children about the adverse effects of drinking.
In related news, women appear to be more vulnerable than men to many adverse consequences of alcohol use. Women achieve higher concentrations of alcohol in the blood and become more impaired than men after drinking equivalent amounts of alcohol. Research also suggests that women are more susceptible than men to alcohol-related organ damage and to trauma resulting from traffic crashes and interpersonal violence.
This issue wraps up with a subject we're sure to hear more about. The death of an adolescent in a medical trial last year has federal health officials investigating whether financial rewards earned by some researchers may
affect patient safety and public health. A new era of biotechnology economics, in which researchers earn millions through stock deals with drug
companies, has raised questions about scientific integrity
and threatens public confidence in medical research.
Articles in today's Vidyya are:
As always, we hope you enjoy the issue.